Annual Current Assets
$18.66 B
-$818.30 M-4.20%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual total current assets is $18.66 billion, with the most recent change of -$818.30 million (-4.20%) on December 31, 2024.
- During the last 3 years, REGN annual current assets has risen by +$4.65 billion (+33.15%).
- REGN annual current assets is now -4.20% below its all-time high of $19.48 billion, reached on December 31, 2023.
Performance
REGN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$18.66 B
-$672.70 M-3.48%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly total current assets is $18.66 billion, with the most recent change of -$672.70 million (-3.48%) on December 31, 2024.
- Over the past year, REGN quarterly current assets has dropped by -$818.30 million (-4.20%).
- REGN quarterly current assets is now -4.20% below its all-time high of $19.48 billion, reached on December 31, 2023.
Performance
REGN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
REGN Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.2% | -4.2% |
| 3 y3 years | +33.1% | -4.2% |
| 5 y5 years | +142.7% | -4.2% |
REGN Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +33.1% | -4.2% | +33.1% |
| 5 y | 5-year | -4.2% | +142.7% | -4.2% | +142.7% |
| alltime | all time | -4.2% | >+9999.0% | -4.2% | >+9999.0% |
Regeneron Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $19.10 B(+40.4%) | $18.66 B(-3.5%) |
| Sep 2024 | - | $19.33 B(+1.3%) |
| Jun 2024 | - | $19.08 B(+1.1%) |
| Mar 2024 | - | $18.87 B(-3.1%) |
| Dec 2023 | $13.60 B(+2.0%) | $19.48 B(+4.5%) |
| Sep 2023 | - | $18.63 B(+10.1%) |
| Jun 2023 | - | $16.92 B(+0.1%) |
| Mar 2023 | - | $16.91 B(+6.5%) |
| Dec 2022 | $13.33 B(+16.7%) | $15.88 B(+3.0%) |
| Sep 2022 | - | $15.43 B(-0.7%) |
| Jun 2022 | - | $15.53 B(+8.6%) |
| Mar 2022 | - | $14.31 B(+2.1%) |
| Dec 2021 | $11.42 B(+54.7%) | $14.01 B(+1.7%) |
| Sep 2021 | - | $13.78 B(+3.3%) |
| Jun 2021 | - | $13.34 B(+32.6%) |
| Mar 2021 | - | $10.06 B(+2.8%) |
| Dec 2020 | $7.38 B(+3.8%) | $9.78 B(+7.5%) |
| Sep 2020 | - | $9.10 B(+15.7%) |
| Jun 2020 | - | $7.86 B(-9.1%) |
| Mar 2020 | - | $8.64 B(+12.4%) |
| Dec 2019 | $7.12 B(+34.6%) | $7.69 B(+8.2%) |
| Sep 2019 | - | $7.11 B(+6.9%) |
| Jun 2019 | - | $6.65 B(-4.0%) |
| Mar 2019 | - | $6.93 B(+7.5%) |
| Dec 2018 | $5.29 B(+19.4%) | $6.45 B(+12.7%) |
| Sep 2018 | - | $5.72 B(+18.8%) |
| Jun 2018 | - | $4.81 B(+5.9%) |
| Mar 2018 | - | $4.54 B(+4.8%) |
| Dec 2017 | $4.43 B(+16.8%) | $4.33 B(+4.8%) |
| Sep 2017 | - | $4.14 B(+7.1%) |
| Jun 2017 | - | $3.86 B(+5.2%) |
| Mar 2017 | - | $3.67 B(+15.4%) |
| Dec 2016 | $3.79 B(+40.8%) | $3.18 B(-9.2%) |
| Sep 2016 | - | $3.50 B(+9.1%) |
| Jun 2016 | - | $3.21 B(+2.4%) |
| Mar 2016 | - | $3.13 B(+7.5%) |
| Dec 2015 | $2.69 B(+53.7%) | $2.92 B(+8.9%) |
| Sep 2015 | - | $2.68 B(+17.2%) |
| Jun 2015 | - | $2.28 B(-1.2%) |
| Mar 2015 | - | $2.31 B(+10.8%) |
| Dec 2014 | $1.75 B(+51.9%) | $2.08 B(-5.3%) |
| Sep 2014 | - | $2.20 B(+14.7%) |
| Jun 2014 | - | $1.92 B(+2.5%) |
| Mar 2014 | - | $1.87 B(+4.1%) |
| Dec 2013 | $1.15 B(+32.0%) | $1.80 B(+10.0%) |
| Sep 2013 | - | $1.63 B(+4.7%) |
| Jun 2013 | - | $1.56 B(+19.5%) |
| Mar 2013 | - | $1.31 B(+8.4%) |
| Dec 2012 | $874.48 M(+32.9%) | $1.21 B(+27.1%) |
| Sep 2012 | - | $948.60 M(+23.3%) |
| Jun 2012 | - | $769.19 M(+10.4%) |
| Mar 2012 | - | $696.91 M(+4.7%) |
| Dec 2011 | $657.81 M(-10.1%) | $665.78 M(+95.9%) |
| Sep 2011 | - | $339.87 M(-17.8%) |
| Jun 2011 | - | $413.27 M(+27.0%) |
| Mar 2011 | - | $325.50 M(-9.0%) |
| Dec 2010 | $731.81 M(+131.8%) | $357.62 M(-37.9%) |
| Sep 2010 | - | $575.72 M(+37.8%) |
| Jun 2010 | - | $417.75 M(+5.6%) |
| Mar 2010 | - | $395.44 M(-7.1%) |
| Dec 2009 | $315.69 M(+55.7%) | $425.51 M(-7.8%) |
| Sep 2009 | - | $461.59 M(-0.7%) |
| Jun 2009 | - | $465.03 M(-3.9%) |
| Mar 2009 | - | $483.79 M(-7.2%) |
| Dec 2008 | $202.78 M(+46.5%) | $521.44 M(-27.1%) |
| Sep 2008 | - | $715.54 M(-3.6%) |
| Jun 2008 | - | $742.39 M(-5.7%) |
| Mar 2008 | - | $787.50 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $138.43 M(+20.3%) | $797.83 M(+89.1%) |
| Sep 2007 | - | $422.02 M(-15.1%) |
| Jun 2007 | - | $496.98 M(+1.6%) |
| Mar 2007 | - | $489.16 M(+4.1%) |
| Dec 2006 | $115.11 M(+40.2%) | $469.98 M(+71.7%) |
| Sep 2006 | - | $273.75 M(-5.9%) |
| Jun 2006 | - | $291.06 M(-8.9%) |
| Mar 2006 | - | $319.65 M(-6.4%) |
| Dec 2005 | $82.11 M(-36.4%) | $341.39 M(+5.1%) |
| Sep 2005 | - | $324.96 M(-9.6%) |
| Jun 2005 | - | $359.31 M(-2.9%) |
| Mar 2005 | - | $369.85 M(+7.5%) |
| Dec 2004 | $129.15 M(-18.9%) | $343.95 M(+10.5%) |
| Sep 2004 | - | $311.24 M(-18.8%) |
| Jun 2004 | - | $383.33 M(-2.3%) |
| Mar 2004 | - | $392.28 M(+22.5%) |
| Dec 2003 | $159.35 M(+39.0%) | $320.21 M(-20.8%) |
| Sep 2003 | - | $404.38 M(+37.0%) |
| Jun 2003 | - | $295.15 M(-10.5%) |
| Mar 2003 | - | $329.74 M(+19.1%) |
| Dec 2002 | $114.63 M(+13.3%) | $276.95 M(-11.8%) |
| Sep 2002 | - | $313.82 M(+1.3%) |
| Jun 2002 | - | $309.70 M(-8.1%) |
| Mar 2002 | - | $337.12 M(-14.5%) |
| Dec 2001 | $101.21 M(+36.5%) | $394.19 M(+56.0%) |
| Sep 2001 | - | $252.73 M(-0.0%) |
| Jun 2001 | - | $252.78 M(-11.8%) |
| Mar 2001 | - | $286.64 M(+113.7%) |
| Dec 2000 | $74.13 M(+15.8%) | $134.14 M(-2.1%) |
| Sep 2000 | - | $137.00 M(-0.3%) |
| Jun 2000 | - | $137.46 M(+87.1%) |
| Mar 2000 | - | $73.48 M(+0.7%) |
| Dec 1999 | $64.00 M(0.0%) | $73.00 M(-1.6%) |
| Sep 1999 | - | $74.20 M(-2.6%) |
| Jun 1999 | - | $76.20 M(0.0%) |
| Mar 1999 | - | $76.20 M(-18.0%) |
| Dec 1998 | $64.00 M(-7.0%) | $92.90 M(+4.1%) |
| Sep 1998 | - | $89.20 M(+0.9%) |
| Jun 1998 | - | $88.40 M(-2.8%) |
| Mar 1998 | - | $90.90 M(-8.7%) |
| Dec 1997 | $68.80 M(+30.8%) | $99.60 M(-2.4%) |
| Sep 1997 | - | $102.10 M(-7.7%) |
| Jun 1997 | - | $110.60 M(+53.8%) |
| Mar 1997 | - | $71.90 M(-15.4%) |
| Dec 1996 | $52.60 M(+17.9%) | $85.00 M(+15.8%) |
| Sep 1996 | - | $73.40 M(-10.2%) |
| Jun 1996 | - | $81.70 M(+112.2%) |
| Mar 1996 | - | $38.50 M(-21.7%) |
| Dec 1995 | $44.60 M(+5.7%) | $49.20 M(+60.8%) |
| Sep 1995 | - | $30.60 M(-22.5%) |
| Jun 1995 | - | $39.50 M(+4.2%) |
| Mar 1995 | - | $37.90 M(-27.1%) |
| Dec 1994 | $42.20 M(+63.6%) | $52.00 M(+10.6%) |
| Sep 1994 | - | $47.00 M(-15.0%) |
| Jun 1994 | - | $55.30 M(+24.0%) |
| Mar 1994 | - | $44.60 M(-51.4%) |
| Dec 1993 | $25.80 M(+95.5%) | $91.80 M(-16.2%) |
| Sep 1993 | - | $109.60 M(+61.9%) |
| Jun 1993 | - | $67.70 M(-11.8%) |
| Mar 1993 | - | $76.80 M(-9.3%) |
| Dec 1992 | $13.20 M(+78.4%) | $84.70 M(-7.8%) |
| Sep 1992 | - | $91.90 M(-5.6%) |
| Jun 1992 | - | $97.40 M(-4.9%) |
| Mar 1992 | - | $102.40 M(-3.9%) |
| Dec 1991 | $7.40 M(+146.7%) | $106.60 M(-2.7%) |
| Sep 1991 | - | $109.60 M(-1.5%) |
| Jun 1991 | - | $111.30 M(+396.9%) |
| Dec 1990 | $3.00 M | $22.40 M |
FAQ
- What is Regeneron Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual current assets year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly current assets year-on-year change?
What is Regeneron Pharmaceuticals annual total current assets?
The current annual current assets of REGN is $18.66 B
What is the all time high annual current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total current assets is $19.48 B
What is Regeneron Pharmaceuticals annual current assets year-on-year change?
Over the past year, REGN annual total current assets has changed by -$818.30 M (-4.20%)
What is Regeneron Pharmaceuticals quarterly total current assets?
The current quarterly current assets of REGN is $18.66 B
What is the all time high quarterly current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total current assets is $19.48 B
What is Regeneron Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, REGN quarterly total current assets has changed by -$818.30 M (-4.20%)